✨ Free AI Report
Fate Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Fate Therapeutics, Inc.
Research Preview

Fate Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

Fate Therapeutics is a clinical-stage biopharmaceutical company developing programmed cellular immunotherapies for cancer and immune disorders. The company is advancing off-the-shelf, multiplexed-engineered cell produ...

Analyst-debate audio for Fate Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for Fate Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Fate Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Challenged

Cyborg Score thesis

Compelling iPSC-cell therapy pipeline with positive Phase 1 autoimmune/oncology data offset by clinical-stage execution risk and...

Read the full analyst-debate transcript →
Industry Biopharmaceutical - Cell & Gene Therapy
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Fate Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Fate Therapeutics, Inc. Overview

Pro stress-test →

Fate Therapeutics is a clinical-stage biopharmaceutical company developing programmed cellular immunotherapies for cancer and immune disorders. The company is advancing off-the-shelf, multiplexed-engineered cell product candidates utilizing its iPSC (induced pluripotent stem cell) platform, which are selectively designed with novel synthetic controls of cell function to deliver multiple therapeutic mechanisms.

Strategic Profile

Pro stress-test →

Fate Therapeutics develops induced pluripotent stem cell (iPSC)-derived, off-the-shelf cellular immunotherapies for cancer and autoimmune diseases. The company's key competitive advantage lies in manufacturing scalable, universal cell products designed to overcome limitations of traditional cell therapies, with a focus on reducing the need for intensive conditioning regimens.

Competitive Landscape

Pro stress-test →

Competitors include Agenus, Sorrento Therapeutics, Beam Therapeutics, BioNTech, and Intellia Therapeutics. Fate differentiates through its proprietary iPSC platform enabling off-the-shelf cell therapies with reduced conditioning requirements and broader manufacturing scalability compared to autologous CAR-T competitors.

Industry Context

Fate Therapeutics, Inc. operates in Biopharmaceutical - Cell & Gene Therapy.

Key facts

Founded: 2007 · Headquarters: San Diego, US · Employees: 181 · Revenue: $7.14M · Market cap: $120M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Fate Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Fate Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

CAR-T Cell TherapiesAutologous CAR-T for hematologic malignancies→Allogeneic Cell TherapiesOff-the-shelf CAR-T derived from iPSC/NK cells→Gene Editing TherapeuticsBase editing for cell and in vivo therapies→iPSC-derived ImmunotherapiesCRISPR-based cell engineering for cancer→

Compare Fate Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Fate Therapeutics, Inc. operates in Biopharmaceutical - Cell & Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical - Cell & Gene Therapy research →
NEW · MCP server

Ask your AI assistant about Fate Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Fate Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did Fate Therapeutics, Inc. do this quarter?”
“Is Fate Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Fate Therapeutics, Inc. do?+
Fate Therapeutics is a clinical-stage biopharmaceutical company developing programmed cellular immunotherapies for cancer and immune disorders. The company is advancing off-the-shelf, multiplexed-engineered cell produ...
What is Fate Therapeutics, Inc.'s Cyborg Score?+
Fate Therapeutics, Inc. has a Cyborg Score of 4/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Fate Therapeutics, Inc.'s main competitors?+
Named competitors include CAR-T Cell Therapies, Allogeneic Cell Therapies, Gene Editing Therapeutics, iPSC-derived Immunotherapies. The full competitive landscape is in the AskCyborg report.
How can I get the full Fate Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Fate Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Fate Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Anthropic9Dubai Electricity and Water Authority (DEWA)9Emaar Development PJSC9Gold Fields Limited9Western Digital Corporation9Advantest Corporation9Fast Retailing Co., Ltd.9JPMorgan Chase & Co.9Siemens AG9Space Exploration Technologies Corp8Arcellx, Inc.8Gentili Mosconi S.p.A.8Neurogene Inc.8Selvaag Bolig ASA8Satellogic Inc.8Klaveness Combination Carriers ASA8Unusual Machines, Inc.8Shoei Co., Ltd.